Copyright
©The Author(s) 2025.
World J Exp Med. Jun 20, 2025; 15(2): 100443
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.100443
Published online Jun 20, 2025. doi: 10.5493/wjem.v15.i2.100443
Table 3 Univariate and multivariate regression analyses of overall survival
| Feature | Univariate analysis | Multivariate analysis | ||
| Hazard ratio (95%CI) | P value | Hazard ratio (95%CI) | P value | |
| Sex | 0.658 (0.259-1.672) | NS | ||
| Chemotherapy | 3.039 (1.077-8.578) | 0.03 | 1.969 (0.594-6.517) | NS |
| T | 1.771 (1.165-2.692) | 0.005 | ||
| N | 2.833 (1.2-6.687) | 0.01 | ||
| M | 4.905 (1.516-15.88) | 0.003 | ||
| Stage | 1.767 (1.146-2.723) | 0.006 | 1.595 (0.950-2.679) | 0.077 |
| IGF1R expression | 2.654 (1.102-6.913) | 0.04 | 3.302 (1.208-9.023) | 0.02 |
- Citation: Wang Q, Fan C, Tsujio G, Sakuma T, Maruo K, Yamamoto Y, Imanishi D, Kawabata K, Nishikubo H, Kanei S, Aoyama R, Kushiyama S, Ohira M, Yashiro M. Establishment and characterization of a new human gallbladder cancer cell line, OCUG-2. World J Exp Med 2025; 15(2): 100443
- URL: https://www.wjgnet.com/2220-315x/full/v15/i2/100443.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i2.100443